Home    |     Featured Information    |     Sitemap    |    
Share | 
Healthcare Professionals
Patients and Families
Healthcare Professionals
Healthcare Professionals

PML is a rare but serious infection of the central nervous system (CNS). The Progressive Multifocal Leukoencephalopathy (PML) Consortium is a joint effort between Pfizer, MedImmune, Roche, and Bristol-Myers Squibb intended to find methods to enable prediction and prevention of PML associated with immunomodulatory and immunosuppressive treatments.

Register Now for 2015 Research Conference

The PML Consortium will hold a research conference on PML on August 25-26, 2015 at AstraZeneca in Mölndal, Sweden. The full program and registration information are available on the conference website. Visit the website and register now!